Pournaras Constantin J, Rungger-Brändle Elisabeth, Riva Charles E, Hardarson Sveinn H, Stefansson Einar
Department of Ophthalmology, Vitreo-Retina Unit, University Hospitals of Geneva, 22 rue Alcide Jentzer, CH-1211 Geneva 14, Switzerland.
Prog Retin Eye Res. 2008 May;27(3):284-330. doi: 10.1016/j.preteyeres.2008.02.002. Epub 2008 Feb 23.
Optimal retinal neuronal cell function requires an appropriate, tightly regulated environment, provided by cellular barriers, which separate functional compartments, maintain their homeostasis, and control metabolic substrate transport. Correctly regulated hemodynamics and delivery of oxygen and metabolic substrates, as well as intact blood-retinal barriers are necessary requirements for the maintenance of retinal structure and function. Retinal blood flow is autoregulated by the interaction of myogenic and metabolic mechanisms through the release of vasoactive substances by the vascular endothelium and retinal tissue surrounding the arteriolar wall. Autoregulation is achieved by adaptation of the vascular tone of the resistance vessels (arterioles, capillaries) to changes in the perfusion pressure or metabolic needs of the tissue. This adaptation occurs through the interaction of multiple mechanisms affecting the arteriolar smooth muscle cells and capillary pericytes. Mechanical stretch and increases in arteriolar transmural pressure induce the endothelial cells to release contracting factors affecting the tone of arteriolar smooth muscle cells and pericytes. Close interaction between nitric oxide (NO), lactate, arachidonic acid metabolites, released by the neuronal and glial cells during neural activity and energy-generating reactions of the retina strive to optimize blood flow according to the metabolic needs of the tissue. NO, which plays a central role in neurovascular coupling, may exert its effect, by modulating glial cell function involved in such vasomotor responses. During the evolution of ischemic microangiopathies, impairment of structure and function of the retinal neural tissue and endothelium affect the interaction of these metabolic pathways, leading to a disturbed blood flow regulation. The resulting ischemia, tissue hypoxia and alterations in the blood barrier trigger the formation of macular edema and neovascularization. Hypoxia-related VEGF expression correlates with the formation of neovessels. The relief from hypoxia results in arteriolar constriction, decreases the hydrostatic pressure in the capillaries and venules, and relieves endothelial stretching. The reestablished oxygenation of the inner retina downregulates VEGF expression and thus inhibits neovascularization and macular edema. Correct control of the multiple pathways, such as retinal blood flow, tissue oxygenation and metabolic substrate support, aiming at restoring retinal cell metabolic interactions, may be effective in preventing damage occurring during the evolution of ischemic microangiopathies.
最佳的视网膜神经元细胞功能需要由细胞屏障提供的适当、严格调控的环境,这些屏障分隔功能区室、维持其稳态并控制代谢底物转运。正确调控的血流动力学以及氧气和代谢底物的输送,以及完整的血视网膜屏障是维持视网膜结构和功能的必要条件。视网膜血流通过肌源性和代谢机制的相互作用进行自动调节,这种相互作用通过血管内皮和围绕小动脉壁的视网膜组织释放血管活性物质来实现。自动调节是通过阻力血管(小动脉、毛细血管)的血管张力适应灌注压力或组织代谢需求的变化来实现的。这种适应通过影响小动脉平滑肌细胞和毛细血管周细胞的多种机制的相互作用而发生。机械拉伸和小动脉跨壁压力的增加会诱导内皮细胞释放影响小动脉平滑肌细胞和周细胞张力的收缩因子。在神经活动和视网膜能量生成反应期间,神经元和神经胶质细胞释放的一氧化氮(NO)、乳酸、花生四烯酸代谢产物之间的密切相互作用,力求根据组织的代谢需求优化血流。在神经血管耦合中起核心作用的NO可能通过调节参与此类血管舒缩反应的神经胶质细胞功能来发挥其作用。在缺血性微血管病的发展过程中,视网膜神经组织和内皮的结构和功能受损会影响这些代谢途径的相互作用,导致血流调节紊乱。由此产生的缺血、组织缺氧和血屏障改变会引发黄斑水肿和新生血管形成。缺氧相关的VEGF表达与新生血管的形成相关。缺氧缓解会导致小动脉收缩,降低毛细血管和小静脉中的静水压力,并减轻内皮拉伸。内视网膜重新建立的氧合会下调VEGF表达,从而抑制新生血管形成和黄斑水肿。正确控制多种途径,如视网膜血流、组织氧合和代谢底物支持,旨在恢复视网膜细胞代谢相互作用,可能有效预防缺血性微血管病发展过程中发生的损伤。